U.S. Markets
Medtronic (MDT) announces that the US FDA has cleared the LigaSure(TM) RAS Maryland jaw device for use with the Hugo(TM) robotic-assisted surgery system
StockNow breaking-news AI analysis
FDA clearances and expanded instrumentation support Medtronic's Hugo RAS platform as it targets over 50,000 cumulative procedures amid increasing competition in soft-tissue robotic surgery.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
